Karl Deisseroth, Peter Hegemann, and Georg Nagel have been awarded the 2026 Nobel Prize in Physiology or Medicine for their groundbreaking work in light-gated ion channels and optogenetics, as announced by the Nobel Assembly in Stockholm on Monday. Optogenetics enables the manipulation of individual nerve cell activity in a living brain, uncovering the brain’s complexities in laboratories worldwide.
The trio, comprising Deisseroth from the U.S., Hegemann and Nagel from Germany, expressed their surprise and gratitude for sharing the prestigious award. They will split the prize amount of 12 million Swedish crowns. Deisseroth is affiliated with Stanford University, Hegemann with Humboldt University, and Nagel with the University of Würzburg in Germany.
Experts, like Anna Wedell from the Nobel committee, believe that optogenetics marks the beginning of a new era in neuroscience, allowing a deeper understanding of brain information processing and neuron interactions. Clinical trials are showing promise in restoring vision to individuals with retinitis pigmentosa by introducing light-sensitive proteins into the retina.
Hegemann’s research in the early 1990s on the alga Chlamydomonas led to the discovery of channelrhodopsin-2, an ion channel activated by light. Deisseroth later demonstrated the technique, termed optogenetics, in nerve cells, paving the way for its application in diverse areas, including improving cochlear implants for enhanced auditory nerve stimulation.
The collaborative efforts of the laureates have revolutionized neuroscientific research, with the impact of their discoveries resonating globally. The Nobel Prizes for physics, chemistry, literature, peace, and economics will be awarded in the upcoming days, continuing the tradition established by Alfred Nobel, the visionary behind these prestigious accolades. Nobel’s legacy, rooted in his desire to benefit humanity, lives on through the annual recognition of outstanding contributions across various fields.
